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Abstract The antimicrobial properties of phenolic extracts
of Portuguese wild edible mushroom species (Lactarius de-
liciosus, Sarcodon imbricatus and Tricholoma portentosum)
against pathogens were investigated. The minimal inhibitory
concentrations (MICs) were evaluated for the entire mush-
room, the cap and the stipe, separately; the portion of the
mushroom used proved to be influenced in the results ob-
tained, which are directly correlated with the content of total
phenols and flavonoids in the extracts. The growth of Gram-
positive bacteria (Bacillus cereus, B. subtilis,) was well in-
hibited by these mushrooms, while Escherichia coli (Gram-
negative bacteria) was resistant. The study on the antifungal
effect of these mushrooms revealed that Candida albicans
and Cryptococcus neoformans were differently inhibited for
the mushrooms used.
Keywords Wild edible mushrooms . Bioactive
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Introduction
Mushrooms are a nutritionally functional food and a source
of physiologically beneficial medicines [1, 2]. Both fruit-
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ing body and the mycelium contain compounds with wide-
ranging antimicrobial activity. Mushrooms are rich sources
of natural antibiotics; in these, the cell wall glucans are well-
known for their immunomodulatory properties, and many of
the externalised secondary metabolites (extracellular secre-
tions by the mycelium) combat bacteria [3, 4] and viruses
[5–8]. Additionally, the exudates from mushroom mycelia
are active against protozoa such as the parasite that causes
malaria, Plasmodium falciparum [9, 10] and other microor-
ganisms [11]. The importance of the Chinese Shiitake mush-
room (Lentinus edodes) is well known; besides its anti-
tumour activity, it has been demonstrated to increase the
host resistance to bacterial and viral infections [12]. Several
compounds extracted from this mushroom revealed antifun-
gal and antibacterial activity [13, 14], namely against Staphy-
lococcus aureus, Bacillus subtilis and Escherichia coli [15].
The chloroform and ethyl acetate extracts of the dried mush-
room have antibacterial activity against Streptococcus mu-
tans and Prevotella intermedia [16]. A few studies have been
reported on the antimicrobial activity of other edible mush-
rooms and its bioactive compounds. Laetiporus sulphureus
antioxidant and antimicrobial activities were reported and
correlated to the phenols and flavonoids contents [17], and
guaiane sesquiterpenoids isolated from the fruit bodies of
edible lactarius species proved to have antibacterial activity
[18].
The northeast of Portugal is one of the European re-
gions with higher wild edible mushrooms diversity, some
of them with great gastronomic relevance. The aim of this
work was to investigate the antimicrobial properties of to-
tal polyphenols of different Portuguese wild edible mush-
rooms. Phenolic compounds have attracted much interest re-
cently because in vitro and in vivo studies suggest that they
have a variety of beneficial biological properties, which may
play an important role in the maintenance of human health.
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152 Eur Food Res Technol (2007) 225:151–156
Phenolics are antioxidants with redox properties, which al-
low them to act as reducing agents, hydrogen donors, free
radical scavengers [19], and singlet oxygen quenchers [20].
They also have metal chelation properties and inhibit lipid
peroxidation [21, 22]. Their significance for the human diet
and antimicrobial activity has been recently established [23,
24]. Some phenolic compounds exhibit various physiological
activities including anti-inflammatory, antiallergic, anticar-
cinogenic, antihypertensive, antiarthritic and antimicrobial
activities [25].
In fact, the enhance prevalence of infectious diseases is
becoming a world wide problem, and the resistance problem
demands that a renewed effort should be made to seek antimi-
crobial agents effective against pathogenic microorganisms
resistant to current treatment. Therefore, the search for new
products with antimicrobial properties is a very active do-
main of research, and herein we suggest natural resources
for that propose.
We report a screening of antibacterial activities using
Gram-positive (Bacillus cereus, B. subtilis) and Gram-
negative bacteria (Pseudomonas aeruginosa, Escherichia
coli) and antifungal (Candida albicans, Cryptococcus ne-
oformans) performed for three important wild edible mush-
room species, Lactarius deliciosus (L.) Gray, Sarcodon
imbricatus (L.) P. Karst., and Tricholoma portentosum
(Fr.) Que´l. from northeast of Portugal. These mushrooms
are largely consumed and even commercialised in Tra´s-
os-Montes region. The entire mushroom, the cap and
the stipe individually were used in order to compare
their activities with bioactive compounds present in each
portion.
Materials and methods
Microorganisms and culture conditions
The bacterial strains used as test organisms were Bacil-
lus cereus CECT 148, B. subtilis CECT 498, Escherichia
coli CECT 101, and Pseudomonas aeruginosa CECT 108,
obtained from the Spanish type culture collection (CECT)
of Valencia University. The fungi strains used were Can-
dida albicans CECT 1394 from the same collection and
Cryptococcus neoformans ESA 1, obtained in Microbiol-
ogy Laboratory of Escola Superior Agra´ria de Braganc¸a.
Microorganisms were cultured aerobically at 37 ◦C in
nutrient agar medium for bacteria, and at 30 ◦C in
sabouraud dextrose agar medium for fungi (oven: Scien-
tific 222 model, 2003). Before experimental use, cultures
from solid medium were subcultivated in liquid media,
incubated (orbital shaker incubator: Stuart Scientific SI50
model, 2001) and used as the source of inoculums for each
experiment.
Chemicals
Gallic acid, ( + )-chatechin and Ciocalteu’s phenol reagent
were from Merck. Methanol was obtained from Pronalab
(Lisboa, Portugal). All other chemicals were obtained from
Sigma Chemical Co. (St. Louis, USA). Water was treated in a
Mili-Q water purification system (TGI Pure Water Systems,
USA).
Mushroom samples
Samples of L. deliciosus (L.) Gray, S. imbricatus (L.) P.
Karst., and T. portentosum (Fr.) Que´l. were collected un-
der live pine trees (Pinus sp.), in Braganc¸a (northeast of
Portugal), in autumn 2004. After collection, the mushrooms
were grouped by taxon and were air-dried in a liophylizator
(Ly-8-FM-ULE, Snijders) before analysis. Taxonomic iden-
tification was made according to several authors [26–30]
and representative voucher specimens were deposited at the
herbarium of Escola Superior Agra´ria of Instituto Polite´cnico
de Braganc¸a.
A fine dried mushroom powder (20 mesh) sample (10 g)
was extracted by stirring with 100 ml of methanol at 25 ◦C at
150 rpm for 24 h and filtered through Whatman N ◦4 paper.
The residue was then extracted with two additional 100 ml
portions of methanol, as described earlier. The combined
methanolic extracts were evaporated at 40 ◦C to dryness.
For agar diffusion assays, the phenolic compounds were
dissolved in DMSO and filter-sterilization through a 0.22 µm
membrane filter. The range of phenolic compounds concen-
trations used includes 500 mg/ml to 0.1 mg/ml. All the assays
were performed using the entire mushroom, the cap or the
stipe separately.
Determination of bioactive components
Phenolic compounds in the mushroom methanolic extracts
were estimated by a colorimetric assay, based on proce-
dures described by Singleton and Rossi with some modi-
fications [31]. Briefly, 1 ml of sample was mixed with 1 ml
of Folin and Ciocalteu’s phenol reagent. After 3 min, 1 ml
of saturated sodium carbonate solution was added to the
mixture and adjusted to 10 ml with distilled water. The
reaction was kept in the dark for 90 min, after which the
absorbance was read at 725 nm (Analytikijena 200-2004
spectrophotometer). Gallic acid was used to calculate the
standard curve (0.01–0.4 mM). Estimation of the pheno-
lic compounds was carried out in triplicate. The results
were mean values ± standard deviations and expressed as
milligrams of gallic acid equivalents (GAEs) per gram of
extract.
Flavonoid contents in the extracts were determined by a
colorimetric method described by Jia et al. [32] with some
Springer
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Table 1 Extraction yield of methanolic extracts from L. deliciosus,
S. imbricatus and T. portentosum
Mushroom sample Yielda (g) Extraction% (w/w)
L. deliciosus
Total 2.00 20.0
Cap 1.43 14.3
Stipe 1.40 14.0
S. imbricatus
Total 1.79 17.9
Cap 1.62 16.2
Stipe 1.60 16.0
T. portentosum
Total 1.69 16.9
Cap 1.52 15.2
Stipe 1.45 14.5
aExtracted from dried mushrooms (10 g).
modifications. The mushroom extract (250 µl) was mixed
with 1.25 ml of distilled water and 75 µl of a 5% NaNO2
solution. After 5 min, 150 µl of a 10% AlCl3·H2O solution
was added. After 6 min, 500 µl of 1 M NaOH and 275 µl of
distilled water were added to the mixture. The solution was
mixed well and the intensity of pink colour was measured
at 510 nm. ( + )-chatechin was used to calculate the stan-
dard curve (0.022–0.34 mM). Estimation of the flavonoid
compounds was carried out in triplicate. The results were
mean values ± standard deviations and expressed as mil-
ligrams of ( + )-chatechin equivalents (CEs) per gram of
extract.
Ascorbic acid was determined according to the method of
Klein and Perry [33]. The dried methanolic extract (100 mg)
was extracted with 10 ml of 1% metaphosphoric acid for
45 min at room temperature and filtered through Whatman
N ◦4 filter paper. The filtrate (1 ml) was mixed with 9 ml of
2,6-dichloroindophenol and the absorbance was measured
within 30 min at 515 nm against a blank. Content of ascorbic
acid was calculated on the basis of the calibration curve
of authentic l-ascorbic acid (0.020–0.12 mg/ml). The assays
were carried out in triplicate; the results were mean values ±
standard deviations and expressed as milligrams of ascorbic
acid per gram of extract.
β-carotene and lycopene were determined according
to the method of Nagata and Yamashita [34]. The dried
methanolic extract (100 mg) was vigorously shaken with
10 ml of acetone–hexane mixture (4:6) for 1 min and filtered
through Whatman N ◦4 filter paper. The absorbance of the
filtrate was measured at 453, 505, 645 and 663 nm. Content
of β-carotene and lycopene was calculated according to the
following equations: Lycopene (mg/100 ml) = –0.0458A663
+ 0.372A505 – 0.0806A453; β-carotene (mg/100 ml) =
0.216A663 – 0.304A505 + 0.452A453. The assays were car-
ried out in triplicate; the results were mean values ± stan-
dard deviations and expressed as milligrams of carotenoid
per gram of extract.
Antimicrobial activity
A screening of antibacterial activities with two Gram-
negative (E. coli, P. aeruginosa) and two Gram-positive
bacteria (B. subtilis, B. cereus) was performed; antifungal
activity (C. albicans, C. neoformans) was also assessed,
and the minimal inhibitory concentrations (MICs in mg/ml)
were determined by an adaptation of the agar streak dilution
method based on radial diffusion [35, 36]. Suspensions of
the microorganism were prepared to contain approximately
108 cfu/ml, and the plates containing agar medium were
inoculated (100 µl). A 50 µl volume of each sample was
pipetted into a hole (depth 3 mm, diameter 4 mm) made in
the centre of the agar. Under the same conditions, different
concentrated solutions of ampicillin (antibacterial) and cy-
cloheximide (antifungal) in DMSO were used as standards.
The MIC was considered to be the lowest concentration of
the tested sample to inhibit growth of bacteria or fungi on the
Table 2 Contents of bioactive compounds found in the mushroom extracts
Mushroom sample Total phenols (mg/g) Flavonoids (mg/g) Ascorbic acid (mg/g) β-carotene (µg/g) Lycopene (µg/g)
L. deliciosus
Total 17.25 ± 0.65 8.14 ± 0.81 0.24 ± 0.02 90.10 ± 4.76 40.71 ± 3.45
Cap 10.66 ± 0.52 4.76 ± 0.11 0.21 ± 0.01 51.00 ± 3.12 25.83 ± 2.12
Stipe 6.31 ± 0.29 3.59 ± 0.16 0.18 ± 0.01 18.50 ± 1.25 5.69 ± 0.62
S. imbricatus
Total 3.76 ± 0.11 2.82 ± 0.09 0.50 ± 0.04 20.40 ± 1.33 10.51 ± 1.00
Cap 2.59 ± 0.10 1.72 ± 0.08 0.36 ± 0.02 12.54 ± 1.11 6.03 ± 0.63
Stipe 1.50 ± 0.06 1.46 ± 0.08 0.19 ± 0.01 7.84 ± 0.75 4.48 ± 0.60
T. portentosum
Total 10.80 ± 0.47 0.40 ± 0.02 0.52 ± 0.04 – –
Cap 6.57 ± 0.31 – 0.31 ± 0.02 – –
Stipe 3.91 ± 0.17 – 0.22 ± 0.02 – –
Note. Each value is expressed as mean ± standard deviation (n = 3); (–) Not detected.
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plate, after 24 h. The diameters of the inhibition zones cor-
responding to the MICs were measured in millimeters with
an accuracy of 0.5 mm using a ruler. Each inhibition zone
diameter was measured three times (three different plates)
and the average was taken; standard deviations were less
than 5%. Positive control using only inoculation and nega-
tive control using only DMSO in the hole were also carried
out.
Results
Three wild edible mushroom species (L. deliciosus, S. imbri-
catus, T. portentosum) from the northeast of Portugal were
evaluated for their content in total phenols, flavonoids, ascor-
bic acid, β-carotene and lycopene, and the obtained extracts
were screened for their antimicrobial activity. The assays
were carried out using the DMSO solutions of the entire
mushroom, the cap and the stipe separately. DMSO was
chosen as solvent after comparative toxicity assays (data not
shown) and was not toxic.
We present in Table 1 the yields from mushrooms ex-
tractions. The yields of extraction with methanol were in the
range of 14–20%, and always higher when we used the entire
mushroom.
Table 2 shows the concentrations of the bioactive com-
pounds found in the mushroom extracts. Whereas total phe-
nols and flavonoids were the major components found in
the mushroom extracts, ascorbic acid was found in small
amounts (0.18–0.52 mg/g), and β-carotene and lycopene
were only found in vestigial amounts (< 91 µg/g).
The portion of the mushroom used (entire, cap or stipe)
had influence in the results obtained. The extracts with the
entire mushroom showed higher phenolic and flavonoid con-
tents either than the cap or the stipe. Also the amount of
phenolic and flavonoid compounds in the cap methanolic
extracts was higher than the amount found in stipe extracts.
The content of total phenols in the mushrooms extracts
might account for the different results found in their antimi-
crobial activity. Table 3 shows the antimicrobial screening
of phenolic compounds extracted from L. deliciosus, S. im-
bricatus and T. portentosum against B. cereus, B. subtilis
(Gram + ), E. coli, P. aeruginosa (Gram − ) bacteria, and C.
albicans and C. neoformans (fungi). The MICs for bacteria
and fungi were determined as an evaluation of the antimi-
crobial activity of the tested mushrooms. The diameters of
the inhibition zones corresponding to the MICs are also pre-
sented.
All the mushrooms revealed antimicrobial activity show-
ing different selectivity and MICs for each microorganism
(Fig. 1). L. deliciosus showed better results than T. portento-
sum and S. imbricatus (lower MICs), which is in agreement
with the higher content of phenols and flavonoids found in
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Fig. 1 Antimicrobial activity
of total phenolic compounds
present in different mushrooms
against selected
microorganisms. a L. deliciosus,
b S. imbricatus and c T.
portentosum. () concentration
of 300 mg/ml, concentration
of 100 mg/ml, () concentration
of 50 mg/ml and
concentration of 10 mg/ml
the first species (Table 2). The entire and the cap mush-
room extracts inhibited B. cereus, B. subtilis, P. aeruginosa,
C. albicans and C. neoformans, while the stipe mushroom
extract only inhibited B. cereus, P. aeruginosa and C. ne-
oformans. Only this mushroom revealed activity against P.
aeruginosa (Gram– bacteria) and C. albicans (fungi), and
for the Gram + bacteria showed lower MICs. The T. por-
tentosum extract was effective only against Gram + bac-
teria (B. cereus, B. subtilis) and C. neoformans. When the
cap was used the same selectivity was obtained, but with
higher MICs; the stipe extract was only effective against B.
cereus. In fact, the content in total phenols and flavonoids
for the stipe extracts was always lower than in the other ex-
tracts. As expected due to its lower content in bioactive com-
pounds, S. imbricatus was the less effective (higher MICs)
mushroom, showing activity only against B. cereus and C.
neoformans. The cap extract was selective for B. cereus,
while the sipe extract was not effective against the tested
microorganisms.
E. coli was resistant to all the mushrooms extracts. As
expected, the standards ampiciline (antibacterial) and cy-
cloheximide (antifungal) presented lower MICs than the
mushrooms extracts. Usually, pure active compounds re-
veal more activity than crude extracts. Searching wild
sources may bring new natural products with antimicro-
bial properties that provide good protection against the
infectious diseases. Therefore, new wild edible mush-
rooms, as natural sources, could be introduced for this
purpose.
On the basis of the above findings, it is concluded that the
antimicrobial activity is direct correlated with the content in
total phenols and flavonoids. The use of the entire mushroom
is recommended and the mushroom cap proved to be better
than the stipe. The extracts of L. deliciosus, S. imbricatus and
T. portentosum inhibited some medically important microor-
ganisms. This suggests that they are potential sources of new
antimicrobial agents. With an increasing number of bacte-
ria developing resistance to commercial antibiotics, such as
MSRA (methicillin-resistant S. aureus and Pseudomonas),
extracts and derivatives from mushrooms hold great promise
for novel medicines in modern times. As far as our literature
survey could ascertain, a few information was available on
the in vitro antimicrobial activities of European wild mush-
rooms and it is the first time that Portuguese wild edible
mushrooms (entire, cap and stipe) were submitted to these
studies.
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